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Insulin-dependent translocation of ARNO to the plasma
membrane of adipocytes requires phosphatidylinositol 3-kinase
Kanamarlapudi Venkateswarlu, Paru B. Oatey, Jeremy M. Tavaré 
and Peter J. Cullen
ADP-ribosylation factors (ARFs) are small GTP-binding
proteins that are regulators of vesicle trafficking in
eukaryotic cells [1]. ARNO is a member of the family of
guanine nucleotide exchange factors for ARFs which
includes cytohesin-1 and GRP-1 [2–5]. Members of this
family contain a carboxy-terminal pleckstrin homology
(PH) domain which, in the case of GRP-1, has been
shown to bind the second messenger
phosphatidylinositol 3,4,5-trisphosphate (PIP3) in
preference to phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2) and phosphatidylinositol 3,4-bisphosphate
(PI(3,4)P2) in vitro [3,4]. Here, we show that
recombinant ARNO has the binding characteristics of a
PIP3 receptor and that this activity is restricted to the
PH domain. When expressed in murine 3T3 L1
adipocytes, ARNO tagged using green fluorescent
protein (GFP) is localised exclusively in the cytoplasm.
Stimulation with insulin, however, causes a rapid
(< 50 second) PH-domain-dependent translocation of
GFP–ARNO to the plasma membrane. This
translocation is blocked by the PI(4,5)P2 3-kinase (PI 3-
kinase) inhibitors wortmannin and LY294002, and by
co-expression with a dominant-negative p85 mutant,
suggesting that the translocation is a consequence of
insulin stimulation of PI 3-kinase. Our data strongly
suggest that ARNO binds PIP3 in vivo and that this
interaction causes a translocation of ARNO to the
plasma membrane where it might activate ARF6 and
regulate subsequent plasma membrane cycling events.
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Results and discussion
Increasing evidence has implicated the 3-phosphorylated
inositol lipids, in particular PIP3, in the regulation of ARF
signalling through their ability to interact with the ARF
exchange factors GRP-1 [3,4], cytohesin-1 [5] and possibly
ARNO. To test whether ARNO binds PIP3, we have iso-
lated a full-length human ARNO cDNA that contains an
open reading frame encoding a protein of 399 amino acids
with a predicted molecular mass of 47 kDa (the protein
sequence is identical to that of the previously cloned
human ARNO [2]). The full-length ARNO cDNA was
cloned into the pGEX4T-3 expression vector to allow
expression and purification of recombinant protein for
binding analysis. 
Our approach to identifying putative PIP3 receptors
stems from our previous work on the characterisation of
receptors for the cytosolic second messenger inositol
1,3,4,5-tetrakisphosphate (IP4) [6]. PIP3 has IP4 as its
inositol headgroup, with the distinction that the 1-phos-
phate is not free, as in IP4, but is attached via glycerol to
the fatty acids (Figure 1a). This has led us to predict that
a PIP3 receptor may in fact bind IP4 in vitro [6]. It would
be expected, however, that esterification of the 1-phos-
phate of IP4, particularly with glycerol or diacetylglycerol
(to form GroPIns(3,4,5)P3 and diacetyl GroPIns(3,4,5)P3,
respectively), would result in a decrease in binding affin-
ity to an IP4 receptor, but would not affect, or might even
increase, the binding affinity to a PIP3 receptor. As
shown in Figure 1b, IP4 bound to ARNO with high affin-
ity and specificity. The Kd value for IP4 (that is, the con-
centration required to compete for 50% of bound
[32P]IP4) was 69.3 ± 4.1 nM (n = 3 from three separate
purifications). The other inositol phosphates tested,
namely Ins(1,3,4,5,6)P5, IP6, Ins(1,4,5)P3 and
Ins(1,3,4)P3, had Kd values of 6,239 ± 352, > 10,000,
> 10,000 and > 10,000 nM, respectively (n = 3 for each
inositol phosphate). GroPIns(3,4,5)P3 and diacetyl
GroPIns(3,4,5)P3 had very similar binding affinities to
that of IP4 (Figure 1b; Kd values of 88.3 ± 10.3 and
79.3 ± 11.2 nM, respectively). 
These results suggest that ARNO does indeed constitute a
putative PIP3 receptor, in that it specifically recognises the
1,3,4,5-phosphate configuration on the inositol ring in pref-
erence to the 1,4,5 or 1,3,4 configuration of PI(4,5)P2 and
PI(3,4)P2, respectively. Moreover, unlike the IP4 receptor
GAP1IP4BP [6], it can accommodate a glycerol substitution
on the 1-phosphate. In order to map this binding site, we
have constructed fusion proteins comprising glutathione-
S-transferase (GST) and either ARNO lacking the
carboxy-terminal PH domain (GST–ARNO∆PH) or
simply the PH domain of ARNO itself (GST–ARNOPH).
Only proteins containing the PH domain bound IP4
(Figure 1c), ARNOPH having a similar affinity and speci-
ficity to full-length ARNO (data not shown).
To overcome the limitations intrinsic to in vitro binding
assays, we have used murine 3T3 L1 adipocytes to
address whether ARNO does indeed interact with PIP3 in
vivo, as stimulation of these cells with insulin results in an
activation of PI 3-kinase and hence an elevation in PIP3
levels [7]. The subcellular localisation of ARNO was
examined using a chimaera of GFP fused to the amino ter-
minus of ARNO (GFP–ARNO). In unstimulated
adipocytes, GFP–ARNO was expressed in the cytoplasm
and was excluded from the nucleus and fat droplets
(Figure 2a). Addition of insulin (200 nM) caused an almost
complete translocation of GFP–ARNO to the plasma
membrane (Figure 2b). This translocation required the
PH domain of ARNO as, first, its deletion prevented
translocation (data not shown) and, second, a fusion
protein between GFP and just the PH domain of ARNO
(amino acids 262–399; GFP–ARNOPH) translocated in
response to insulin with a similar time course to that of
full-length ARNO (Figure 2c,d).
To address whether this translocation required the activa-
tion of PI 3-kinase, we preincubated transfected
adipocytes with the chemically unrelated PI 3-kinase
inhibitors wortmannin or LY294002 [8,9]. In the absence
of any inhibitor, insulin caused a translocation of
GFP–ARNO in 94.2% of the cells (n = 33), whereas in the
presence of 100 nM wortmannin, the insulin-dependent
translocation of GFP–ARNO occurred in only 4.3% of cells
(n = 23). Similarly, in the presence of 50 µM LY294002,
insulin-induced translocation occurred in only 5.5% of cells
(n = 36). Finally, insulin-induced translocation occurred in
just 3.7% of cells (n = 34) when we co-expressed a domi-
nant-negative p85 (∆p85), which blocks the elevation in
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Pharmacological characterisation of IP4 binding to ARNO.
(a) Schematic representation of PIP3 and IP4. (b) Characterisation of
IP4 binding to a fusion protein of glutathione-S-transferase (GST) and
full-length ARNO, compared with that of other inositol phosphates.
Each data point is from three independent determinations. Scatchard
analysis revealed a single class of binding site (data not shown).
[32P]IP4 competition binding assays were performed as described in
[15] and the isolation of GST fusion proteins achieved as in [16].
(c) Mapping of the IP4-binding site to the PH domain of ARNO by
testing the level of IP4 binding to GST fusion proteins of ARNO, the
PH domain of ARNO (ARNOPH) and ARNO lacking the PH domain
(ARNO∆PH).
Figure 2
Insulin-induced translocation of GFP–ARNO to the plasma membrane
is dependent on a functional PH domain. Murine 3T3 L1 adipocytes
were microinjected with plasmids containing either (a,b) GFP–ARNO
or (c,d) GFP–ARNOPH. After 24 h, the cells were serum starved and
then imaged by laser-scanning confocal microscopy in the absence of
insulin (a,c). The cells were then incubated in the presence of 200 nM
insulin, and imaged again after 1 min (b,d). The scale bar is 10 µm. The
nuclear localisation of GFP–ARNOPH is due to its small size
(approximately 37 kDa), which allows free access through the nuclear
pore which is restricted for the larger 74 kDa GFP–ARNO.
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PIP3 by uncoupling the ability of activated tyrosine-kinase
receptors to stimulate PI 3-kinase [10].
Using time-lapse confocal microscopy we have examined
the kinetics of the translocation of full-length
GFP–ARNO. An initial appearance of GFP–ARNO at the
plasma membrane occurred within 30 seconds of insulin
addition, and was complete within 50 seconds, at which
time an almost total clearance of cytosolic GFP–ARNO
had occurred (Figure 3a). Of particular interest was the
rapid appearance of GFP–ARNO in membrane ruffles.
Time-lapse confocal imaging of cells previously treated
with insulin demonstrated that addition of wortmannin
(100 nM) promoted rapid displacement of GFP–ARNO
from the plasma membrane back into the cytosol, a process
that was completed within 60–70 seconds (Figure 3b). The
dynamics of these translocations can be seen by viewing
the animated sequence available as Supplementary mater-
ial (published with this paper on the internet).
In summary therefore, we have clearly demonstrated that
the ability of insulin to stimulate PI 3-kinase is vital for
the translocation of ARNO to the plasma membrane in
3T3 L1 adipocytes. This, along with the in vitro binding
data and the rapid kinetics of insulin and wortmannin
action on GFP–ARNO subcellular distribution, strongly
suggest that ARNO is interacting with PIP3 in vivo. Con-
sequently, using time-lapse confocal microscopy, we can
visualise the dynamics of PIP3 production within the
plasma membrane of single living cells. As ARNO has
been shown to function as an exchange factor for the
plasma-membrane-located ARF6 [11,12], we would
propose that the ability of ARF6 to regulate membrane
cycling events at the plasma membrane [13] might be
under the control of PIP3.
Materials and methods
Cloning of human ARNO
Homologous primers (sense 5′-CGGAATTCCATGGAGGACGGCGT-
TTATGAA-3′ {primer 1} and antisense 5′-CGCGTCGACTCAGGGCT-
GCTCCTGCTTCTT-3′ {primer 2}) designed from the published human
ARNO sequence [2], were used to amplify by High Fidelity PCR
(Boehringer), full-length ARNO from a human circulating-blood cDNA
library (Strategene No. 938202). The product was digested with EcoRI
and SalI and cloned into the corresponding sites of both the
pGEX4T-3 (Pharmacia) and pEGFP-C1 (Clontech) vectors. All con-
structs were fully sequenced before use.
Cloning of pGEX-ARNO and pEGFP-ARNO deletion mutants
The deletion mutants were produced by PCR with primers designed to
amplify the required fragment of cDNA (for ARNO∆PH, primers were
sense primer 1 and antisense 5′-CGCGTCGACTCAGTCATTCCCGT-
CATCCTCAGG-3′; for ARNOPH, sense 5′-CGGAATTCCATGCGG-
GAGGGCTGGCTCCTGAAG-3′ and antisense primer 2). PCR
products were digested with EcoRI and SalI before ligation into the
corresponding sites within pGEX4T-3 and pEGFP-C1. All constructs
were fully sequenced before use.
Microinjection and confocal microscopy of 3T3 L1 adipocytes
Murine 3T3 L1 adipocytes were differentiated on glass coverslips
coated with poly-lysine and were microinjected with plasmid
(200 µg/ml) as described previously [14]; 24 h later, the adipocytes
were serum starved for 5 h before fluorescence analysis at 37°C in
Krebs–Ringer phosphate buffer (136 mM NaCl, 4.7 mM KCl, 1.25 mM
MgSO4, 1.25 mM CaCl2, 5 mM sodium phosphate) containing 2 mM
NaHCO3 and 25 mM HEPES, pH 7.4. Confocal microscopy was per-
formed with a Leica DM IRBE inverted confocal microscope controlled
with TCS-NT4 software (Leica).
Supplementary material
A time-lapse movie sequence of the translocation of ARNO to and from
the plasma membrane is published with this paper on the internet.
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Figure 3
Time-lapse confocal imaging of the effect of
insulin stimulation on the subcellular
localisation of GFP–ARNO in 3T3 L1
adipocytes. Full-length GFP–ARNO was
expressed in 3T3 L1 adipocytes by
microinjection of plasmid DNA. A selected cell
was imaged 24 h later; the number in each
panel indicates the time (in seconds) at which
the image was taken. (a) Time-lapse sequence
showing the translocation of GFP–ARNO to
the plasma membrane. Images were taken
10 sec apart, with insulin (200 nM; INS) being
added immediately after collecting the 30 sec
image. (b) Time-lapse sequence of the return
of GFP–ARNO to the cytosol following
addition of wortmannin (100 nM; WM) in the
continual presence of 200 nM insulin. The
same cell as in (a) was again imaged at 10 sec
intervals and wortmannin was added after
collecting the image at 10 sec. The time-lapse
movie sequence is available as Supplementary
material (published with this paper on the
internet).
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